Correlation Between Entia Biosciences and Evolus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Entia Biosciences and Evolus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entia Biosciences and Evolus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entia Biosciences and Evolus Inc, you can compare the effects of market volatilities on Entia Biosciences and Evolus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entia Biosciences with a short position of Evolus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entia Biosciences and Evolus.

Diversification Opportunities for Entia Biosciences and Evolus

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Entia and Evolus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Entia Biosciences and Evolus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evolus Inc and Entia Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entia Biosciences are associated (or correlated) with Evolus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evolus Inc has no effect on the direction of Entia Biosciences i.e., Entia Biosciences and Evolus go up and down completely randomly.

Pair Corralation between Entia Biosciences and Evolus

Given the investment horizon of 90 days Entia Biosciences is expected to under-perform the Evolus. In addition to that, Entia Biosciences is 1.44 times more volatile than Evolus Inc. It trades about -0.09 of its total potential returns per unit of risk. Evolus Inc is currently generating about 0.12 per unit of volatility. If you would invest  771.00  in Evolus Inc on January 19, 2024 and sell it today you would earn a total of  385.00  from holding Evolus Inc or generate 49.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Entia Biosciences  vs.  Evolus Inc

 Performance 
       Timeline  
Entia Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Entia Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Entia Biosciences is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Evolus Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evolus Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Evolus is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Entia Biosciences and Evolus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Entia Biosciences and Evolus

The main advantage of trading using opposite Entia Biosciences and Evolus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entia Biosciences position performs unexpectedly, Evolus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolus will offset losses from the drop in Evolus' long position.
The idea behind Entia Biosciences and Evolus Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
CEOs Directory
Screen CEOs from public companies around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Global Correlations
Find global opportunities by holding instruments from different markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments